XTX Topco »

Aeglea Biotherapeutics shares owned by XTX Topco

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by XTX Topco

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2M 24k 50.44
2025-03-31 $460k 29k 16.14

More positions owned by XTX Topco

Ishares Msci Sth Kor Etf (EWY)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
State Str Spdr Dow Jones Ind Ut Ser 1 (DIA)
Cme (CME)
NVIDIA Corporation (NVDA)
Citigroup Com New (C)
Duke Energy Corp Com New (DUK)
Goldman Sachs (GS)
Ge Aerospace Com New (GE)
Boston Scientific Corporation (BSX)
Parker-Hannifin Corporation (PH)
Amazon (AMZN)
American Electric Power Company (AEP)
Visa Com Cl A (V)
Dow (DOW)

View all positions for XTX Topco

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Fairmount Funds Management
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Driehaus Capital Management
State Street Corporation
Paradigm Biocapital Advisors
Commodore Capital
TCG Crossover Management
Tang Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3

View all funds holding Aeglea Biotherapeutics